BRISTOL-MYERS SQUIBB COMPANY CORP
- Country
- United States
- Type
- Beneficiary
- Website
- www.bms.com/landing/data/index.html
- Grants received
- 16
Funding record
- 16 grants on record
- €57,572 awarded in total
- 2011–2025 span of the record
Grants recorded here are the ones our sources publish, and the total is the sum of those. It is not a statement of this organisation's total funding.
Programmes
10 further grants are on record without a programme named by the source, or under a programme outside the largest shown here.
Frequent partners
Organisations this one has been funded alongside on two or more projects. A single shared consortium is not counted: the largest here has 195 members, and being on one list together is not a collaboration.
- ABBVIE INC
- JANSSEN PHARMACEUTICA NV
- ASTRAZENECA AB
- GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED
- ELI LILLY AND COMPANY LTD
- NOVARTIS PHARMA AG
- BAYER AKTIENGESELLSCHAFT
- KAROLINSKA INSTITUTET
Calls from this organisation
No published calls from this organisation.
Grants received
- Research in Europe and Diversity Inclusion
- Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research
- Synthetic Data Generation Framework for Integrated Validation of Use Cases and AI Healthcare Applications
- CLinical impact through AI-assisted MS care
- GUIding multi-moDal thErapies against MRD by liquid biopsies - GUIDE.MRD
- FrAmework for ClInicaL trIal participants daTA reutilization for a fully Transparent and Ethical ecosystem
- Health Initiatives in Psoriasis and PsOriatic arthritis ConsoRTium European States
- Accelerating Research & Development for Advanced Therapies
- Prioritisation and Risk Evaluation of Medicines in the EnviRonment
- Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases
- Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions
- Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation
- NEw Clinical Endpoints in primary Sjögren’s Syndrome: an Interventional Trial based on stratifYing patients
- Liver Investigation: Testing Marker Utility in Steatohepatitis
- Rheuma Tolerance for Cure
Data source
© European Union, 2026. Source: CORDIS. Reused under Commission Decision 2011/833/EU — CC BY 4.0.
Retrieved from the source on .
Personal data of natural persons has been dissociated by quiescence.eu.
This service is not affiliated with, sponsored or endorsed by the data publishers.